Hanshang Group Co., Ltd.

600774

CNE000000NC5

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
9.02 ^CNY	+10.00%		+24.41%	-8.52%

25/04	Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
25/04	Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hanshang Group Co., Ltd. agreed to acquire 81.34% stake in Wuhan Tongji Technology Group Co., Ltd.

January 11, 2023

Hanshang Group Co., Ltd. (SHSE:600774) agreed to acquire 81.34% stake in Wuhan Tongji Technology Group Co., Ltd. on November 4, 2022. Hanshang Group won the bid for stake in Wuhan Tongji Technology Group . As the winner of the bid, Hanshang Group Co., Ltd paid a deposit of CNY 20 million.

Latest news about Hanshang Group Co., Ltd.

Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Meilleure Health Sells 661,408 Shares of Hanshang Group	10/01	MT
Hanshang Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Hanshang Group Co., Ltd. agreed to acquire Zhen An Industrial Co., Ltd. from Zall International Commercial Management Wuhan Partnership Enterprise (Limited Partnership) and Zhen Property Limited.	23/23/23	CI
Hanshang Group Co., Ltd. announced a financing transaction	22/23/22	CI
Meilleure Health Further Disposes of Hanshang Shares for HK$7.1 Million	11/23/11	MT
Meilleure Health Sells 1.4 Million Shares in Hanshang Group	06/23/06	MT
Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.	25/23/25	CI
Hanshang Group Co., Ltd.'s Equity Buyback announced on May 25, 2022 has closed with 6,024,130 shares, representing 2.06% for CNY 75.48 million.	24/23/24	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25	CI
Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.	01/23/01	CI
Hanshang Group Co., Ltd. agreed to acquire 81.34% stake in Wuhan Tongji Technology Group Co., Ltd.	11/23/11	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Tranche Update on Hanshang Group Co., Ltd.'s Equity Buyback Plan announced on May 25, 2022.	05/22/05	CI
Hanshang Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	25/22/25	CI
Hanshang Group Co., Ltd. authorizes a Buyback Plan.	25/22/25	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30	CI
Hanshang Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Wuhan Hanshang Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/21/29	CI
Wuhan Hanshang Group Co.,Ltd. announced that it has received CNY 915.73518 million in funding from a group of investors	09/21/09	CI
Wuhan Hanshang Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/21/30	CI

Chart Hanshang Group Co., Ltd.

Duration

Period

More charts

Company Profile

Hanshang Group Co Ltd, formerly Wuhan Hanshang Group Co Ltd is a China-based company principally engaged in the retail of commodities. The Company is also engaged in the exhibition business, hotel business, tourism business and property management business. The Company mainly operates its retail business through department stores, shopping malls and specialty stores. The Company mainly operates 21st Century Shopping Mall, Ginza Mall and Wuzhan Shopping Center.

Sector

Pharmaceuticals

Calendar

16/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HANSHANG GROUP CO., LTD.	-8.52%	328M
ELI LILLY AND COMPANY	+32.36%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.40%	358B
MERCK & CO., INC.	+19.46%	328B
ABBVIE INC.	+3.50%	283B
ASTRAZENECA PLC	+16.34%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+8.62%	165B

Other Pharmaceuticals